Moreover, inclusion of intestinal resident immune cells, especially ILCs, in on‐chip IEB models may eliminate the need for external inflammatory triggers, such as IFN‐γ, and help to better recapitulate the intestinal immune microenvironment at the onset of IBD. The gene discussed is IFNG; the disease is inflammatory bowel disease.